NCT04774211 is a clinical trial of SOS-PD in Pediatric Delirium, sponsored by Rigshospitalet, Denmark.

Who is sponsoring NCT04774211?

NCT04774211 is sponsored by Rigshospitalet, Denmark.

What drugs are being tested in NCT04774211?

Interventions in NCT04774211: SOS-PD.

What condition does NCT04774211 study?

NCT04774211 studies Pediatric Delirium.

Is NCT04774211 still recruiting?

NCT04774211 is currently completed. Last updated 31 August 2022.

Last reviewed 2022-08-31 · How we verify

NCT04774211

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Prospective Prevalence and Validation Study of Pediatric Intensive Care Delirium.

Completed Last updated 31 August 2022

What this trial tests

trial testing SOS-PD in Pediatric Delirium in 141 participants. Completed in 30 June 2022.

Timeline

1 January 2021

Primary endpoint
30 June 2022

30 June 2022

Quick facts

Lead sponsor	Rigshospitalet, Denmark
Status	Completed
Study type	OBSERVATIONAL
Enrollment	141
Start date	1 January 2021
Primary completion	30 June 2022
Estimated completion	30 June 2022
Sites	1 location across Denmark

Drugs / interventions tested

SOS-PD

Conditions studied

Pediatric Delirium — all drugs for Pediatric Delirium →

Sponsor

Rigshospitalet, Denmark

Who can join

Adults 3 Months to 18, any sex, with Pediatric Delirium. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Pediatric delirium (PD) is a poorly investigated clinical problem that needs to be further explored in a Danish context. Children are at risk of discomfort and suffering if they experience delirium. The condition is associated with prolonged mechanical ventilation, longer hospital stay, increased mortality, and risk of long-term cognitive impairment. Therefore, it is important to assess critically ill children with a validated tool to enable early detection and management of the condition. In this study, the investigators will determine the prevalence of pediatric intensive care delirium. To this end, the investigators will validate the Sophia Observation withdrawal Symptoms - Pediatric delirium scale (SOS-PD) for patient assessment.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Rigshospitalet, Denmark trials

Trials by the same sponsor.

NCT07401368 — Clinicians' Trust in AI-Based Fetal Growth Estimates · NA · not yet recruiting
NCT07442357 — The Per-procedural Antibiotic Prophylaxis in Patients Undergoing Transcatheter Aortic Valve Implantation Trial · NA · not yet recruiting
NCT07528729 — Alcohol as a Modifiable Risk Factor for Atrial Fibrillation · NA · not yet recruiting
NCT07511439 — Reversible Effects of Oral Contraceptive Removal on Serotonergic Neurotransmission · Phase 4 · not yet recruiting
NCT07467187 — Invasive Home Ventilation in Denmark · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04774211 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Rigshospitalet, Denmark
Last refreshed: 31 August 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04774211.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing